950210.KS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 06:38):

Prestige BioPharma Limited, a biopharmaceutical company, engages in the research, development, and marketing of biosimilars and new antibody therapeutics in the Asia Pacific...

Stats
Dzisiejszy wolumen	5 771.00
Średni wolumen	56 686.00
Kapitalizacja rynkowa	482.57B
EPS	KRW-238.40 ( 2023-03-31 )
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW6.98 (0.09%)

Wolumen Korelacja

Długi: -0.27 (neutral)

Krótki: 0.73 (moderate)

Signal:(58.215) Neutral

Prestige BioPharma Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Prestige BioPharma Korelacja - Waluta/Towar

0.69
( moderate )

0.56
( weak )

0.29
( neutral )

0.53
( weak )

-0.21
( neutral )

-0.16
( neutral )

Prestige BioPharma Finanse

Annual	2022
Przychody:	KRW161.84M
Zysk brutto:	KRW-11.50B (-7 103.88 %)
EPS:	KRW292.58

FY	2022
Przychody:	KRW161.84M
Zysk brutto:	KRW-11.50B (-7 103.88 %)
EPS:	KRW292.58

FY	2022
Przychody:	KRW0
Zysk brutto:	KRW0 (0.00 %)
EPS:	KRW-3 519.20

FY	2021
Przychody:	KRW0.00
Zysk brutto:	KRW0.00 (0.00 %)
EPS:	KRW-866.40

Financial Reports:

No articles found.

Prestige BioPharma

Prestige BioPharma Limited, a biopharmaceutical company, engages in the research, development, and marketing of biosimilars and new antibody therapeutics in the Asia Pacific. The company primarily engages in the development of new and similar antibody drugs for solid tumor, pancreatic cancer, breast cancer, gastric cancer, and arthritis. It is also developing vaccines for COVID-19 virus. The company was incorporated in 2015 and is headquartered in Singapore.